Yipeng Yu

889 total citations
21 papers, 648 citations indexed

About

Yipeng Yu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yipeng Yu has authored 21 papers receiving a total of 648 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yipeng Yu's work include Bladder and Urothelial Cancer Treatments (4 papers), Epigenetics and DNA Methylation (4 papers) and Ferroptosis and cancer prognosis (4 papers). Yipeng Yu is often cited by papers focused on Bladder and Urothelial Cancer Treatments (4 papers), Epigenetics and DNA Methylation (4 papers) and Ferroptosis and cancer prognosis (4 papers). Yipeng Yu collaborates with scholars based in China, Canada and United States. Yipeng Yu's co-authors include Daming Zhang, Cheng Zhang, KY Lee, Jing Bai, Jiang Zhu, Yin Zhao, Xianyu Meng, Feng Chen, Tengda Wang and Wei Xue and has published in prestigious journals such as Bioresource Technology, Scientific Reports and British Journal of Cancer.

In The Last Decade

Yipeng Yu

20 papers receiving 638 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yipeng Yu China 11 408 285 98 81 65 21 648
Fuyin Zhang China 12 345 0.8× 188 0.7× 55 0.6× 164 2.0× 40 0.6× 27 622
Kexin Sun China 13 368 0.9× 264 0.9× 69 0.7× 220 2.7× 32 0.5× 50 906
Jing Qing China 15 500 1.2× 120 0.4× 73 0.7× 93 1.1× 20 0.3× 27 943
Natalia Gorlatova United States 16 438 1.1× 278 1.0× 58 0.6× 107 1.3× 107 1.6× 16 885
Xinyu Bian China 14 447 1.1× 245 0.9× 43 0.4× 93 1.1× 25 0.4× 38 733
Zhuochao Liu China 16 290 0.7× 146 0.5× 79 0.8× 140 1.7× 12 0.2× 36 690
Kanthida Kusonmano Thailand 20 490 1.2× 205 0.7× 112 1.1× 166 2.0× 12 0.2× 44 950
Xiaojie Ding China 15 377 0.9× 84 0.3× 45 0.5× 172 2.1× 17 0.3× 45 1.0k
Haipeng Huang China 11 311 0.8× 133 0.5× 142 1.4× 119 1.5× 42 0.6× 32 534
Jiancheng Wang China 20 604 1.5× 179 0.6× 100 1.0× 137 1.7× 12 0.2× 45 1.3k

Countries citing papers authored by Yipeng Yu

Since Specialization
Citations

This map shows the geographic impact of Yipeng Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yipeng Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yipeng Yu more than expected).

Fields of papers citing papers by Yipeng Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yipeng Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yipeng Yu. The network helps show where Yipeng Yu may publish in the future.

Co-authorship network of co-authors of Yipeng Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Yipeng Yu. A scholar is included among the top collaborators of Yipeng Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yipeng Yu. Yipeng Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Yu, Yipeng, et al.. (2024). Efficacy and safety analysis of neoadjuvant chemotherapy combined with immunotherapy in patients with muscle-invasive bladder cancer. Frontiers in Immunology. 15. 1479743–1479743. 1 indexed citations
4.
Zheng, Mengqi, et al.. (2023). Hybrid biofilm system based on corncob coupling with scrap iron for synergistic nitrogen removal and phosphorus recovery in low-carbon source wastewater. Journal of Water Process Engineering. 54. 104006–104006. 3 indexed citations
5.
Xue, Wei, et al.. (2023). Knockdown of SETD2 promotes erastin-induced ferroptosis in ccRCC. Cell Death and Disease. 14(8). 539–539. 16 indexed citations
6.
Yao, Wenhao, et al.. (2022). FBXL6 depletion restrains clear cell renal cell carcinoma progression. Translational Oncology. 26. 101550–101550. 8 indexed citations
7.
Li, Zhiyuan, Zhinan Xia, Yipeng Yu, et al.. (2022). A pyroptosis-associated signature plays a role in prognosis prediction in clear cell renal cell carcinoma. BMC Medical Genomics. 15(1). 204–204. 3 indexed citations
8.
Wang, Zhiming, Mengqi Zheng, Chunhua He, et al.. (2022). Enhanced treatment of low-temperature and low carbon/nitrogen ratio wastewater by corncob-based fixed bed bioreactor coupled sequencing batch reactor. Bioresource Technology. 351. 126975–126975. 37 indexed citations
9.
Xia, Zhinan, Tengda Wang, Wei Xue, et al.. (2022). Identification of a differentiation-related prognostic nomogram based on single-cell RNA sequencing in clear cell renal cell carcinoma. Scientific Reports. 12(1). 10973–10973. 3 indexed citations
10.
Li, Mingyang, Xingyuan Wang, Yipeng Yu, et al.. (2021). RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway. Molecular Medicine Reports. 24(6). 6 indexed citations
11.
Tao, Ran, Wenbin Niu, Shaobin Ni, et al.. (2020). Nucleobindin‑2 enhances the epithelial‑mesenchymal transition in renal cell carcinoma. Oncology Letters. 19(6). 3653–3664. 17 indexed citations
12.
Yu, Yipeng, et al.. (2020). BMP8A promotes survival and drug resistance via Nrf2/TRIM24 signaling pathway in clear cell renal cell carcinoma. Cancer Science. 111(5). 1555–1566. 24 indexed citations
13.
Wang, Gang, Zijian Zhang, Panhong Liu, et al.. (2019). Novel long noncoding RNA OTUD6B-AS1 indicates poor prognosis and inhibits clear cell renal cell carcinoma proliferation via the Wnt/β-catenin signaling pathway. Molecular Cancer. 18(1). 15–15. 104 indexed citations
14.
Yu, Yipeng, Gang Wang, Changlin Wang, et al.. (2019). Inhibition of MicroRNA-381 Promotes Tumor Cell Growth and Chemoresistance in Clear-Cell Renal Cell Carcinoma. Medical Science Monitor. 25. 5181–5190. 10 indexed citations
15.
Wang, Changlin, Gang Wang, Zijian Zhang, et al.. (2018). The downregulated long noncoding RNA <em>DHRS4-AS1</em> is protumoral and associated with the prognosis of clear cell renal cell carcinoma. OncoTargets and Therapy. Volume 11. 5631–5646. 16 indexed citations
16.
Xue, Wei, Panhong Liu, Changlin Wang, et al.. (2018). The effect of Hsa_circ_0001451 in clear cell renal cell carcinoma cells and its relationship with clinicopathological features. Journal of Cancer. 9(18). 3269–3277. 33 indexed citations
17.
Li, Haoming, Gang Wang, Yipeng Yu, et al.. (2018). α-1,2-Mannosidase MAN1C1 Inhibits Proliferation and Invasion of Renal Clear Cell Carcinoma. Journal of Cancer. 9(24). 4618–4626. 15 indexed citations
18.
Huang, Jingchang, Ning Duan, Peng Ji, et al.. (2018). A Crowdsource-Based Sensing System for Monitoring Fine-Grained Air Quality in Urban Environments. IEEE Internet of Things Journal. 6(2). 3240–3247. 63 indexed citations
19.
Lv, Lei, Han‐Xiang Deng, Daming Zhang, et al.. (2014). The DNA methylation-regulated miR-193a-3p dictates the multi-chemoresistance of bladder cancer via repression of SRSF2/PLAU/HIC2 expression. Cell Death and Disease. 5(9). e1402–e1402. 95 indexed citations
20.
Meng, Xianyu, Yipeng Yu, Jing Bai, et al.. (2009). Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion. British Journal of Cancer. 101(2). 327–334. 188 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fuyin Zhang Breakdown of academic impact, for papers by Kexin Sun Breakdown of academic impact, for papers by Jing Qing Breakdown of academic impact, for papers by Natalia Gorlatova Breakdown of academic impact, for papers by Xinyu Bian Breakdown of academic impact, for papers by Zhuochao Liu Breakdown of academic impact, for papers by Kanthida Kusonmano Breakdown of academic impact, for papers by Xiaojie Ding Breakdown of academic impact, for papers by Haipeng Huang Breakdown of academic impact, for papers by Jiancheng Wang
Rankless by CCL
2026